Home
Nath Bio-genes (india) Ltd Board of Directors
Board of Directors at Nath Bio-Genes (India) Ltd
Director
Independent Director
Company Sec. & Compli. Officer
Independent Director
Director
Key Highlights
- Satish Kagliwal continues to serve as the Managing Director in 2024, maintaining the same position as in the previous year.
- Dhiraj Rathi continues to serve as the Company Sec. & Compli. Officer in 2024, maintaining the same position as in the previous year.
- Jeevanlata Kagliwal joins the board as Executive Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Ashu Jain continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
- Vadla Nagbhushanam continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.

Nath Bio-Genes (India) Ltd
NSE: NATHBIOGEN
Share Price
Last Ten Days Market Price
Date | |
---|---|
22 Apr 2025 | 167.7 |
21 Apr 2025 | 168.5 |
17 Apr 2025 | 168.1 |
16 Apr 2025 | 162.3 |
15 Apr 2025 | 155.55 |
11 Apr 2025 | 152 |
09 Apr 2025 | 149.3 |
08 Apr 2025 | 150.15 |
07 Apr 2025 | 148.15 |
04 Apr 2025 | 157 |
Company Fundamentals for Nath Bio-Genes (India) Ltd
Market Cap
320 Cr
EPS
20.4
P/E Ratio (TTM)
8.3
P/B Ratio (TTM)
0.5
Day’s High
172.0
Day’s Low
165.95
DTE
0.2
ROE
6.4
52 Week High
264.5
52 Week Low
141.1
ROCE
6.7
Market Price of Nath Bio-Genes (India) Ltd
1M
1Y
3Y
5Y
Nath Bio-Genes (India) Ltd News Hub
Nath Bio-Genes (India) consolidated net profit declines 0.24% in the June 2024 quarter
Net profit of Nath Bio-Genes (India) declined 0.24% to Rs 33.35 crore in the quarter ended June 2024
Read more
07 Aug 24
Nath Bio-Genes (India) announces board meeting date
Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 23 October 20
Read more
17 Oct 24
Nath Bio-Genes (India) standalone net profit rises 79.50% in the September 2024 quarter
Net profit of Nath Bio-Genes (India) rose 79.50% to Rs 2.89 crore in the quarter ended September 202
Read more
23 Oct 24
Nath Bio-Genes (India) consolidated net profit declines 26.49% in the September 2024 quarter
Net profit of Nath Bio-Genes (India) declined 26.49% to Rs 1.11 crore in the quarter ended September
Read more
23 Oct 24